ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics

Jin, Mei; Fang, Jian; Wang, Jiao-jiao; Shao, Xin; Xu, Suo-wen; Liu, Pei-qing*; Ye, Wen-cai*; Liu, Zhi-ping*南方医科大学; 中山大学; 1
Acta Pharmacologica Sinica2023-12DOI: 10.1038/s41401-023-01123-5
3被引12阅读
引用收藏
分享

摘要

Atherosclerosis, one of the life-threatening cardiovascular diseases (CVDs), has been demonstrated to be a chronic inflammatory disease, and inflammatory and immune processes are involved in the origin and development of the disease. Toll-like receptors (TLRs), a class of pattern recognition receptors that trigger innate immune responses by identifying pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), regulate numerous acute and chronic inflammatory diseases. Recent studies reveal that TLRs have a vital role in the occurrence and development of atherosclerosis, including the initiation of endothelial dysfunction, interaction of various immune cells, and activation of a number of other inflammatory pathways. We herein summarize some other inflammatory signaling pathways, protein molecules, and cellular responses associated with TLRs, such as NLRP3, Nrf2, PCSK9, autophagy, pyroptosis and necroptosis, which are also involved in the development of AS. Targeting TLRs and their regulated inflammatory events could be a promising new strategy for the treatment of atherosclerotic CVDs. Novel drugs that exert therapeutic effects on AS through TLRs and their related pathways are increasingly being developed. In this article, we comprehensively review the current knowledge of TLR signaling pathways in atherosclerosis and actively seek potential therapeutic strategies using TLRs as a breakthrough point in the prevention and therapy of atherosclerosis.

学科与关键词

关键词
cardiovascular diseasesatherosclerosisToll-like receptorsendothelial dysfunctionimmune cellsinflammatory pathways
相关
加载中…
  • Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy
    Cen, Xiaohong; Wang, Baoqu; Liang, Yuqing; Chen, Yanlin; Xiao, Yu; Du, Shaohua; Nandakumar, Kutty Selva; Yin, Hang*; Liu, Shuwen*; Cheng, Kui*Acta Pharmaceutica Sinica B, 2022, 12(9): 3667-3681.被引 5
  • An update on the role of TRIM/NLRP3 signaling pathway in atherosclerosis
    Liu, Sibo; Bi, Hongfeng; Jiang, Meiling; Chen, Yuanli; Jiang, Meixiu*Biomedicine and Pharmacotherapy, 2023, 160: 114321.被引 1
  • Periodontopathic Microbiota and Atherosclerosis: Roles of TLR-Mediated Inflammation Response
    Zou, Yang; Huang, Yaowei; Liu, Siqin; Yang, Juan; Zheng, Wenxia; Deng, Yiting; Zhang, Miaoyu; Yan, Zhenxing*; Xie, Huifang*Oxidative Medicine and Cellular Longevity, 2022, 2022: 9611362.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Pharmacologica Sinica
发表日期
2023-12
卷期
第 44 卷, 第 12 期
页码
2358-2375
DOI
10.1038/s41401-023-01123-5
语言
ENGLISH
期刊收录
CAST-P
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82270500, 81870324, 82203304, U21A20419]; Science and Technology Project of Huadu District in Guangzhou [21-HDWS-007]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01Y093, 2017BT01Y036]

作者

  • J

    Jin, Mei (第一作者)

  • F

    Fang, Jian

    southern med univ

查看全部 8 位作者收起作者
  • W

    Wang, Jiao-jiao

  • S

    Shao, Xin

  • X

    Xu, Suo-wen

    1 · univ sci & technol china · ustc

  • L

    Liu, Pei-qing (通讯)

    new · sun yat sen univ

  • Y

    Ye, Wen-cai (通讯)

  • L

    Liu, Zhi-ping (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417